ProfSamuel McConkey
Professor
International Health Tropical Medicine
Orcid identifier0000-0001-9085-7793 (opens in a new tab)
- ProfessorInternational Health Tropical Medicine
- 01 4022204 (Work)
- RCSI, International Health & Tropical Medicine, Beaux Lane House, Dublin, Dublin 2
RESEARCH OVERVIEW
Malaria Vaccines
International Health
Integrated development
Medical Education
Infectious Disease prevention.
International Health
Integrated development
Medical Education
Infectious Disease prevention.
GRANTS
- FUNDED PROJECTA Phase 3b, multi-center, randomized, parallel group, open-label, non-inferiority study evaluating the efficacy, safety, and tolerability of oral dolutegravir/lamivudine once-daily as a first-line regimen compared to oral bictegravir/emtricitabine/tenofovir alafenamide once daily for Virologic suppression and maintenance in antiretroviral therapy naive adults living with HIVIndustry – Company Sponsored Clinical Trial23 Sep 2024 - 22 Sep 2026
- FUNDED PROJECTStipend increase for non state-funded PhD scholarsRCSI1 Jan 2024 - 30 Sep 2029
- FUNDED PROJECTA Phase IIIb, Randomized, Multicenter, Active-controlled, Parallel-group, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety and Tolerability of Switching to Long-Acting Cabotegravir plus Long-acting Rilpivirine administered every two months from a Bictegravir/emtricitabine/tenofovir alafenamide single tablet regimen in HIV-1 infected adults who are virologically suppressedIndustry19 Feb 2021 - 2 Aug 2027People funded by this grant:
- GlaxoSmithKline UKL
- GRANTA Phase IIIb, Randomized, Multicenter, Active-controlled, Parallelgroup, Non-inferiority, Open-label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine administered every two months from a Bictegravir/emtricitabine/tenofovir alfenamide Single Tablet Regimen in HIV-1 Infected Adults who are Virologically Suppressed.This study is sponsored by ViiV Healthcare. GlaxoSmithKline is supporting ViiV Healthcare in the conduct of this study.29 Nov 2020 - 26 Feb 2021
- GRANTA Prospective Study of Cardiovascular Risk in Patients with HIV Attending a Regional Outpatients Department in IrelandHealth Research Board (Ireland)24 Jun 2019 - 19 Aug 2019People funded by this grant:
- McConkey S,
- Cleary A
- FUNDED PROJECTMulti-country, non-interventional, cohort study of the effectiveness, safety, adherence, and health-related quality of life in HIV-1 infected adult patientsGilead14 May 2019 - 23 Feb 2023
- FUNDED PROJECTRCSI Research Summer School 2019RCSI12 Apr 2019 - 31 Jan 2022
- FUNDED PROJECTDeputy Dean for International Curriculum DevelopmentRCSI12 Feb 2019 - 31 Mar 2027
- GRANTMulti-country, non-interventional, cohort study of the effectiveness, safety, adherence, and health-related quality of life in HIV-1 infected adult patients receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF)Gilead Sciences Europe Ltd. (GSEL)28 Jan 2018 - 27 Jan 2022People funded by this grant:
- Jackson A,
- Lambert J,
- Fleming C
- FUNDED PROJECTHCV within Ireland’s migrant population: patient experiences and challenges in HCV healthcarePrivate Donor3 Oct 2016 - 2 Oct 2017
- FUNDED PROJECTEstablishment and maintenance of a Hepatitis C treatment database for the Department of Infectious Disease in Beaumont Hospital for patients seeking care in the RCSI hospitals regionIndustry30 May 2016 - 31 Dec 2016People funded by this grant:
- Admin A
- FUNDED PROJECTUnderstanding Health Information Systems and Decision-Making for Health: Case study based on new malaria surveillance system in The Gambia.RCSI11 Jan 2016 - 11 Jul 2016
- GRANTUnderstanding Hep C treatment for migrantsICORN1 Jan 2016
- FUNDED PROJECTA multi-centre, prospective, placebo-controlled, randomised trial of short course alendronate therapy to prevent loss of bone mineral density in antiretroviral-naïve, HIV-1 infected subjects initiatinHealth Research Board / HRB1 Jan 2015 - 31 Dec 2018People funded by this grant:
- Paddy M
- GRANTAPART clinical trial, HRB, Dublin – Randomised controlled trial of use of alendronate to prevent osteoporosis in people living with HIVHealth Research Board (Ireland)1 Jan 2015
- GRANTHep C scale upGilead and AbbVie1 Jan 2015
- FUNDED PROJECTDARUNAVIRIndustry5 Dec 2011 - 23 Nov 2015
- FUNDED PROJECTA Circumsporozoite protein vaccine against malaria using the adenovirus Ch63 vector: preclinical and phase 1 safety & immunogenicity studies.European Vaccine Initiative1 Sep 2011 - 31 Oct 2013People funded by this grant:
- Alfredo N,
- Adrian H
- FUNDED PROJECTePredictis- Enterprise Ireland funding for salary for locum to facilitate Prof Mcconkey grant writingEnterprise Ireland26 Sep 2010 - 21 Dec 2012
- GRANTClinical Audit & Clinical Risk ManagementMerck, Sharp & Dohme1 Jan 2009
- GRANTCS Vac. Vectored vaccines for malaria Phase I trialsEMVI1 Jan 2009
- FUNDED PROJECTEvaluate the use of systematic National Surveillance to inform decision-making in malaria prevention and control in The GambiaHealth Research Board / HRB1 Jan 2008 - 31 Jul 2012People funded by this grant:
- Ayo P,
- Climent C-P,
- Sana S,
- Abdoulie C,
- Malang F
- FUNDED PROJECTClinical Research Nurse for Dublin City HIV cohort and Prostate Cancer ConsortiumPrivate Donor10 Dec 2007 - 31 Aug 2013
- GRANTDublin City HIV Cohort- Proposal for Research Nurse at Beaumont HospitalGilead1 Jan 2007
- GRANTDevelopment of high-throughput, cheap and reliable assays for monitoring HIV-1 and HIV-2 in ARV programmes and clinical trials in developing countriesEuropean and Developing Countries Clinical Trials Partnership1 Jan 2004